Initiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective
Author:
Funder
Novo Nordisk
Publisher
Elsevier BV
Reference38 articles.
1. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019;Dia Care,2019
2. An audit of insulin usage and insulin injection practices in a large indian cohort;Baruah;Indian J Endocrinol Metab,2017
3. Systemic barriers to diabetes management in primary care: a qualitative analysis of Delaware physicians;Elliott;Am J Med Qual,2011
4. Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis;Ellis;BMC Fam Pract,2018
5. Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients;Esposito;Diabetes Obes Metab,2012
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Insulin Access Enhancement in India: Expert Views on Integrating Interchangeable Biosimilar Insulin Glargine;Cureus;2024-05-24
2. A Hybrid Model of In-Person and Telemedicine Diabetes Education and Care for Management of Patients with Uncontrolled Type 2 Diabetes Mellitus: Findings and Implications from a Multicenter Prospective Study;Telemedicine Reports;2024-02-01
3. Mitochondrial Dysfunction and Imeglimin: A New Ray of Hope for the Treatment of Type-2 Diabetes Mellitus;Mini-Reviews in Medicinal Chemistry;2023-10-10
4. First-in-class oral semaglutide: Overcoming barriers of incretinisation in the Indian context;Indian Journal of Endocrinology and Metabolism;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3